Barger, Diana
Hessamfar, Mojgan
Neau, Didier
Farbos, Sophie
Leleux, Olivier
Cazanave, Charles
Rouanes, Nicolas
Duffau, Pierre
Lazaro, Estibaliz
Rispal, Patrick
Dabis, François
Wittkop, Linda
Bonnet, Fabrice
Funding for this research was provided by:
Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ECTZ117276 2020-1, ECTZ100440 2019-2)
Article History
Received: 3 April 2023
Accepted: 23 September 2023
First Online: 2 October 2023
Competing interests
: MH, DN, SF, OL, NR, PD, CC, EL, PR, FD, and LW have no relevant financial or nonfinancial competing interests to disclose. DB received speaking fees from Gilead Sciences and ViiV Healthcare and was compensated as an expert on a Gilead Sciences advisory board outside the submitted work. FB reports non-financial support from Gilead Sciences, Janssen, ViiV Healthcare, and MSD, and personal fees from Gilead Sciences, Janssen, ViiV Healthcare, and MSD outside the submitted work.